Journal list Promote Sponsor
verified SJR 1,312 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Emerging Themes in Epidemiology
United Kingdom · BioMed Central Ltd
workspace_premium Q1 — Epidemiology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Emerging Themes in Epidemiology

Emerging Themes in Epidemiology is a journal indexed in SJR in Epidemiology with an H index of 46. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2090 €. The scope of the journal is focused on biology of disease, epidemiology. It has an SJR impact factor of 1,312 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,312.

Publisher: BioMed Central Ltd
Category: Epidemiology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,312 Q1
H-index 46
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
28 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.090 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,312

H-index

46

Docs (year)

0

Docs 3y

31

Total refs

0

Cites 3y

123

Citable 3y

28

Cites/Doc 2y

3.42

Ref/Doc

0.0

Immediate OA

2090 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs